Four integrated technologies for Biologics developability assessment

December 13, 2022

The decisions you make about your biologics candidates early in the pipeline ultimately affect their success as therapeutics.

Combine sizing and stability information to gain valuable insight into the viability of your protein-based biologic candidates, enabling you to select the best ones for further development.

The technologies inside the Prometheus Panta provide high-quality information about your candidates’ purity, size, thermal stability, and aggregation, which enables better pipeline decisions.

Learn more about how Prometheus Panta helps biologics researchers.

Previous Video
Explore Prometheus Panta – Biologics developability assessment with four integrated technologies
Explore Prometheus Panta – Biologics developability assessment with four integrated technologies

Developability assessment is a critical part of the evaluation and selection of candidates for further opti...

Up next
Explore Prometheus Panta – Frequently asked questions about stability profiling experiments
Explore Prometheus Panta – Frequently asked questions about stability profiling experiments

In this video, Nathan Wallace, Application Specialist at NanoTemper, addresses common questions about exper...

Ready to tackle your challenging stability characterizations?

Discover tools